SLCO1B3 and hepatocellular carcinoma: The introduction of MRI studies with hepatospecific contrast agents has improved the diagnostic performance of HCC, especially in the identification and characterization of lesions with atypical features as there is a reduction in the immunohistochemical expression of the uptake transporter OATP8 during multistep hepatocarcinogenesis [12].